Loading...
Back to narrative

AnalystConsensusTarget updated the narrative for ANRG

Update shared on 24 Oct 2025

n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
136.2%
7D
1.6%

Analysts have revised their price target for Anaergia to $5.00 per share from $5. This change reflects slight adjustments to profit margin estimates and future valuation multiples.

What's in the News

  • Anaergia's subsidiary signed an agreement to advance a major renewable natural gas project in Riverside, California. The Riverside Bioenergy Facility will be sold to a developer with institutional investor backing. Anaergia expects to recognize revenue of CAD 39 million for engineering, procurement, and construction services between 2026 and 2027. (Key Developments)
  • Anaergia S.r.l. entered into a contract with Norbiogas Renovables to supply technology and services for a new anaerobic digestion plant, with operations beginning this month. The completed facility will convert organic waste into renewable biomethane and is expected to generate CAD 18 million in revenue. (Key Developments)
  • Anaergia S.r.l. signed a binding agreement with a leading Spanish company to provide services and technology for over 15 new biomethane production plants in Spain. This contract, valued at CAD 184 million, is Anaergia's largest capital sale to date. All projects are expected to be operational within forty-eight months. (Key Developments)

Valuation Changes

  • Consensus Analyst Price Target has remained virtually unchanged at $5.00 per share.
  • Discount Rate has risen slightly, increasing from 6.29% to 6.30%.
  • Revenue Growth estimate is stable and is holding steady at approximately 35.60%.
  • Net Profit Margin forecast has fallen significantly from 6.58% to 4.62%.
  • Future P/E ratio projection has increased notably from 52.37x to 74.60x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.